69 related articles for article (PubMed ID: 7863189)
1. [Open questions about HIV/AZT].
Garattini S
Riv Inferm; 1994; 13(2):104-6. PubMed ID: 7863189
[No Abstract] [Full Text] [Related]
2. Zidovudine and lamivudine: results of phase III studies.
Staszewski S
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S57. PubMed ID: 8595510
[TBL] [Abstract][Full Text] [Related]
3. Report on a 3-year follow-up zidovudine (AZT) treatment in a group of HIV-positive patients with congenital clotting disorders.
Sartori MT; Mares M; Zerbinati P; Stocco D; Girolami A
Haematologia (Budap); 1994; 26(1):17-27. PubMed ID: 7959371
[TBL] [Abstract][Full Text] [Related]
4. 3TC/AZT: just another combination.
GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362997
[TBL] [Abstract][Full Text] [Related]
5. Loss of zidovudine related mutations in the reverse transscriptase gene of HIV after switching therapy.
Falkensammer B; El Attal R; Müllauer B; Sarcletti M; Parson W; Dierich MP; Stoiber H
Eur J Med Res; 2002 Sep; 7(9):379-86. PubMed ID: 12435615
[TBL] [Abstract][Full Text] [Related]
6. AZT benefits HIV-positive asymptomatic people: new hope, new challenges.
Lewis A
AIDS Educ Prev; 1989; 1(4):347. PubMed ID: 2641256
[No Abstract] [Full Text] [Related]
7. [Progression of HIV infection halved: early AZT therapy--advantage confirmed in a large European-Australian study].
Toeller V
Pharm Unserer Zeit; 1993 Nov; 22(5-6):263. PubMed ID: 8121928
[No Abstract] [Full Text] [Related]
8. Education needed after AZT failure.
Nurs Stand; 1993 Apr 7-13; 7(29):6. PubMed ID: 8499278
[No Abstract] [Full Text] [Related]
9. Mothers shown to transmit resistant strains to babies.
AIDS Alert; 1995 Nov; 10(11):137-8. PubMed ID: 11362924
[TBL] [Abstract][Full Text] [Related]
10. [AZT and 3TC treatment in a pregnant woman with HIV infection].
Pardo MJ; Pedrol E; Coll M; Montull S
Med Clin (Barc); 1999 Mar; 112(9):358-9. PubMed ID: 10220772
[No Abstract] [Full Text] [Related]
11. Alert! Don't abbreviate zidovudine as AZT.
Aspens Advis Nurse Exec; 1993 Mar; 8(6):2. PubMed ID: 8443025
[No Abstract] [Full Text] [Related]
12. [Resistance of human immunodeficiency virus (HIV) to zidovudine. Genotypic analysis in strains isolated from Chilean patients].
Vial PA; Vial C; Abarca K; Noriega M; Jiménez G; Labarca J; Gasep J; Palacios O; Pérez C; Acuña G
Rev Med Chil; 1998 Jan; 126(1):17-26. PubMed ID: 9629750
[TBL] [Abstract][Full Text] [Related]
13. AZT in Africa.
Kottow MH
J Clin Ethics; 1999; 10(2):166-7. PubMed ID: 10633289
[No Abstract] [Full Text] [Related]
14. Physicians not fazed by AZT guidelines.
Macilwain C
Nature; 1993 Jul; 364(6433):93. PubMed ID: 8321294
[No Abstract] [Full Text] [Related]
15. Another option for less than 50 T4 cells.
Treat Rev; 1995; (no 19):3. PubMed ID: 11362755
[TBL] [Abstract][Full Text] [Related]
16. [Low doses of AZT: is it really a good option?].
Calva JJ; Sierra-Madero JG
Rev Invest Clin; 1993; 45(2):179-81. PubMed ID: 8337546
[No Abstract] [Full Text] [Related]
17. [Efficacy and tolerance of a combination of AZT, DDC, and saquinavir in patients infected with the human immunodeficiency virus].
Soriano Vázquez V; Rodríguez-Rosado Martínez-Echevarría R; Jiménez-Nacher I; Valencia Ortega E; Moreno Celda V; González-Lahoz J
Rev Clin Esp; 1998 Sep; 198(9):634-5. PubMed ID: 9803794
[No Abstract] [Full Text] [Related]
18. Studies of zidovudine in combination with didanosine and zalcitabine.
Jablonowski H
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
[TBL] [Abstract][Full Text] [Related]
19. Insurance company to pay for AZT.
J Ark Med Soc; 1989 Nov; 86(6):247. PubMed ID: 2530207
[No Abstract] [Full Text] [Related]
20. FDA notifications. FDA approves generic AZT.
AIDS Alert; 2007 Jul; 22(7):79. PubMed ID: 17763553
[No Abstract] [Full Text] [Related]
[Next] [New Search]
